|
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 June 2004 | Volume 140 Issue 11 | Pages 958-963
Translation research transforms currently available knowledge into useful measures for everyday clinical and public health practice. We review the progress in diabetes translation research and identify future challenges and opportunities in this field. Several promising interventions to optimize implementation of efficacious diabetes treatments are available. Many of these interventions, singly or in combination, need to be more formally tested in larger randomized or quasi-experimental practical trials using outcomes of special interest to patients (for example, patient satisfaction and quality of life) and policymakers (for example, cost and cost-effectiveness). The long-term outcomes (such as morbidity, mortality, quality of life, and costs) of strategies aimed at improving diabetes care must be assessed. Translation research also needs to incorporate ways of studying complex systems of care. The challenges and opportunities offered by translation research are tremendous.
Author and Article Information
From the Centers for Disease Control and Prevention, Atlanta, Georgia.
Acknowledgments: The authors thank Farah Chowdhury for her assistance in preparing this manuscript.
Potential Financial Conflicts of Interest: None disclosed.
Requests for Single Reprints: K.M. Venkat Narayan, MD, Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Mailstop K-10, 4770 Buford Highway NE, Atlanta, GA 30341.
Current Author Addresses: Drs. Narayan, Gregg, Norris, and Engelgau: Division of Diabetes Translation, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Mailstop K-10, 4770 Buford Highway NE, Atlanta, GA 30341.
Dr. Benjamin: Baystate Medical Center, 759 Chestnut Street, Springfield, MA 01199. SUPPLEMENT: DIABETES TRANSLATION AND PUBLIC HEALTH: 25 YEARS OF CDC RESEARCH AND PROGRAMS
K.M. Venkat Narayan, MD, MPH, MBA; Leonard Jack Jr., PhD; and Christine Laine, MD, MPH, Editors
Diabetes Translation Research: Where Are We and Where Do We Want To Be?
![]()
This article has been cited by other articles:
![]() |
L. G. Planas Intervention design, implementation, and evaluation Am. J. Health Syst. Pharm., October 1, 2008; 65(19): 1854 - 1863. [Abstract] [Full Text] [PDF] |
||||
![]() |
M E J Lean, J I Mann, J A Hoek, R M Elliot, and G Schofield Translational research BMJ, August 28, 2008; 337(aug28_1): a863 - a863. [Full Text] |
||||
![]() |
A. H. Zai, R. W. Grant, G. Estey, W. T. Lester, C. T. Andrews, R. Yee, E. Mort, and H. C. Chueh Lessons from Implementing a Combined Workflow-Informatics System for Diabetes Management J. Am. Med. Inform. Assoc., July 1, 2008; 15(4): 524 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. De Civita and K. Dasgupta Using diffusion of innovations theory to guide diabetes management program development: an illustrative example J. Public Health Med., September 1, 2007; 29(3): 263 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.M. V. Narayan, P. Zhang, D. Williams, M. Engelgau, G. Imperatore, A. Kanaya, and A. Ramachandran How should developing countries manage diabetes? Can. Med. Assoc. J., September 26, 2006; 175(7): 733 - 733. [Full Text] [PDF] |
||||
![]() |
A C. J W Janssens, M. Gwinn, R. Valdez, K M V. Narayan, and M. J Khoury Predictive genetic testing for type 2 diabetes. BMJ, September 9, 2006; 333(7567): 509 - 510. [Full Text] [PDF] |
||||
![]() |
K. G. Shojania, S. R. Ranji, K. M. McDonald, J. M. Grimshaw, V. Sundaram, R. J. Rushakoff, and D. K. Owens Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA, July 26, 2006; 296(4): 427 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Benjamin Now Is the Time to Improve Quality of Diabetes Care DOC News, August 1, 2005; 2(8): 4 - 4. [Full Text] |
||||
![]() |
J. W. Mold and K. A. Peterson Primary Care Practice-Based Research Networks: Working at the Interface Between Research and Quality Improvement Ann. Fam. Med, May 1, 2005; 3(suppl_1): S12 - S20. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.M. V. Narayan The Diabetes Pandemic: Looking for the Silver Lining Clin. Diabetes, April 1, 2005; 23(2): 51 - 52. [Full Text] [PDF] |
||||
![]() |
J. A. Johnson, D. T. Eurich, E. L. Toth, R. Z. Lewanczuk, T. Lee, and S. R. Majumdar Generalizability and Persistence of a Multifaceted Intervention for Improving Quality of Care for Rural Patients With Type 2 Diabetes Diabetes Care, April 1, 2005; 28(4): 783 - 788. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Moreno and V. Fuster New aspects in the pathogenesis of diabetic atherothrombosis J. Am. Coll. Cardiol., December 21, 2004; 44(12): 2293 - 2300. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. Tierney, B. L. Cadwell, M. M. Engelgau, L. Shireley, S. L. Parsons, K. Moum, and L. S. Geiss Declining Mortality Rate Among People With Diabetes in North Dakota, 1997-2002 Diabetes Care, November 1, 2004; 27(11): 2723 - 2725. [Full Text] [PDF] |
||||
![]() |
K.M. V. Narayan "Polypill" for Cardiovascular Disease Prevention Clin. Diabetes, October 1, 2004; 22(4): 157 - 158. [Abstract] [Full Text] [PDF] |
||||